世界のヒトエリスロポエチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Erythropoietin Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5785 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ヒトエリスロポエチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他）、用途別市場規模（貧血、腎疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヒトエリスロポエチンの市場動向 ・企業の競争状況、市場シェア ・ヒトエリスロポエチンの種類別市場規模と予測2016-2027（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他） ・ヒトエリスロポエチンの用途別市場規模と予測2016-2027（貧血、腎疾患、その他） ・ヒトエリスロポエチンの北米市場規模2016-2027（アメリカ、カナダ） ・ヒトエリスロポエチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトエリスロポエチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトエリスロポエチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトエリスロポエチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences） ・結論

Market Analysis and Insights: Global Human Erythropoietin Market
The global Human Erythropoietin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Erythropoietin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Erythropoietin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Erythropoietin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Erythropoietin market.

Global Human Erythropoietin Scope and Market Size
Human Erythropoietin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Erythropoietin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Segment by Application
Anemia
Kidney Disorders
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Erythropoietin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Erythropoietin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Erythropoietin Market Perspective (2016-2027)
2.2 Human Erythropoietin Growth Trends by Regions
2.2.1 Human Erythropoietin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Erythropoietin Historic Market Share by Regions (2016-2021)
2.2.3 Human Erythropoietin Forecasted Market Size by Regions (2022-2027)
2.3 Human Erythropoietin Industry Dynamic
2.3.1 Human Erythropoietin Market Trends
2.3.2 Human Erythropoietin Market Drivers
2.3.3 Human Erythropoietin Market Challenges
2.3.4 Human Erythropoietin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Erythropoietin Players by Revenue
3.1.1 Global Top Human Erythropoietin Players by Revenue (2016-2021)
3.1.2 Global Human Erythropoietin Revenue Market Share by Players (2016-2021)
3.2 Global Human Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Erythropoietin Revenue
3.4 Global Human Erythropoietin Market Concentration Ratio
3.4.1 Global Human Erythropoietin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Erythropoietin Revenue in 2020
3.5 Human Erythropoietin Key Players Head office and Area Served
3.6 Key Players Human Erythropoietin Product Solution and Service
3.7 Date of Enter into Human Erythropoietin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Erythropoietin Breakdown Data by Type
4.1 Global Human Erythropoietin Historic Market Size by Type (2016-2021)
4.2 Global Human Erythropoietin Forecasted Market Size by Type (2022-2027)

5 Human Erythropoietin Breakdown Data by Application
5.1 Global Human Erythropoietin Historic Market Size by Application (2016-2021)
5.2 Global Human Erythropoietin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Erythropoietin Market Size (2016-2027)
6.2 North America Human Erythropoietin Market Size by Type
6.2.1 North America Human Erythropoietin Market Size by Type (2016-2021)
6.2.2 North America Human Erythropoietin Market Size by Type (2022-2027)
6.2.3 North America Human Erythropoietin Market Size by Type (2016-2027)
6.3 North America Human Erythropoietin Market Size by Application
6.3.1 North America Human Erythropoietin Market Size by Application (2016-2021)
6.3.2 North America Human Erythropoietin Market Size by Application (2022-2027)
6.3.3 North America Human Erythropoietin Market Size by Application (2016-2027)
6.4 North America Human Erythropoietin Market Size by Country
6.4.1 North America Human Erythropoietin Market Size by Country (2016-2021)
6.4.2 North America Human Erythropoietin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Human Erythropoietin Market Size (2016-2027)
7.2 Europe Human Erythropoietin Market Size by Type
7.2.1 Europe Human Erythropoietin Market Size by Type (2016-2021)
7.2.2 Europe Human Erythropoietin Market Size by Type (2022-2027)
7.2.3 Europe Human Erythropoietin Market Size by Type (2016-2027)
7.3 Europe Human Erythropoietin Market Size by Application
7.3.1 Europe Human Erythropoietin Market Size by Application (2016-2021)
7.3.2 Europe Human Erythropoietin Market Size by Application (2022-2027)
7.3.3 Europe Human Erythropoietin Market Size by Application (2016-2027)
7.4 Europe Human Erythropoietin Market Size by Country
7.4.1 Europe Human Erythropoietin Market Size by Country (2016-2021)
7.4.2 Europe Human Erythropoietin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Erythropoietin Market Size (2016-2027)
8.2 Asia-Pacific Human Erythropoietin Market Size by Type
8.2.1 Asia-Pacific Human Erythropoietin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Erythropoietin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Erythropoietin Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Erythropoietin Market Size by Application
8.3.1 Asia-Pacific Human Erythropoietin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Erythropoietin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Erythropoietin Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Erythropoietin Market Size by Region
8.4.1 Asia-Pacific Human Erythropoietin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Erythropoietin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Erythropoietin Market Size (2016-2027)
9.2 Latin America Human Erythropoietin Market Size by Type
9.2.1 Latin America Human Erythropoietin Market Size by Type (2016-2021)
9.2.2 Latin America Human Erythropoietin Market Size by Type (2022-2027)
9.2.3 Latin America Human Erythropoietin Market Size by Type (2016-2027)
9.3 Latin America Human Erythropoietin Market Size by Application
9.3.1 Latin America Human Erythropoietin Market Size by Application (2016-2021)
9.3.2 Latin America Human Erythropoietin Market Size by Application (2022-2027)
9.3.3 Latin America Human Erythropoietin Market Size by Application (2016-2027)
9.4 Latin America Human Erythropoietin Market Size by Country
9.4.1 Latin America Human Erythropoietin Market Size by Country (2016-2021)
9.4.2 Latin America Human Erythropoietin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Erythropoietin Market Size (2016-2027)
10.2 Middle East & Africa Human Erythropoietin Market Size by Type
10.2.1 Middle East & Africa Human Erythropoietin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Erythropoietin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Erythropoietin Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Erythropoietin Market Size by Application
10.3.1 Middle East & Africa Human Erythropoietin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Erythropoietin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Erythropoietin Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Erythropoietin Market Size by Country
10.4.1 Middle East & Africa Human Erythropoietin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Erythropoietin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Human Erythropoietin Introduction
11.1.4 Amgen Revenue in Human Erythropoietin Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Human Erythropoietin Introduction
11.2.4 Johnson & Johnson Revenue in Human Erythropoietin Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Human Erythropoietin Introduction
11.3.4 Roche Revenue in Human Erythropoietin Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Galenica
11.4.1 Galenica Company Details
11.4.2 Galenica Business Overview
11.4.3 Galenica Human Erythropoietin Introduction
11.4.4 Galenica Revenue in Human Erythropoietin Business (2016-2021)
11.4.5 Galenica Recent Development
11.5 Emcure
11.5.1 Emcure Company Details
11.5.2 Emcure Business Overview
11.5.3 Emcure Human Erythropoietin Introduction
11.5.4 Emcure Revenue in Human Erythropoietin Business (2016-2021)
11.5.5 Emcure Recent Development
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Company Details
11.6.2 Kyowa Hakko Kirin Business Overview
11.6.3 Kyowa Hakko Kirin Human Erythropoietin Introduction
11.6.4 Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2016-2021)
11.6.5 Kyowa Hakko Kirin Recent Development
11.7 3SBio
11.7.1 3SBio Company Details
11.7.2 3SBio Business Overview
11.7.3 3SBio Human Erythropoietin Introduction
11.7.4 3SBio Revenue in Human Erythropoietin Business (2016-2021)
11.7.5 3SBio Recent Development
11.8 Biocon
11.8.1 Biocon Company Details
11.8.2 Biocon Business Overview
11.8.3 Biocon Human Erythropoietin Introduction
11.8.4 Biocon Revenue in Human Erythropoietin Business (2016-2021)
11.8.5 Biocon Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Details
11.9.2 LG Life Sciences Business Overview
11.9.3 LG Life Sciences Human Erythropoietin Introduction
11.9.4 LG Life Sciences Revenue in Human Erythropoietin Business (2016-2021)
11.9.5 LG Life Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Erythropoietin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Epoetin-alfa
Table 3. Key Players of Epoetin-beta
Table 4. Key Players of Darbepoetin-alfa
Table 5. Key Players of Others
Table 6. Global Human Erythropoietin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Erythropoietin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Human Erythropoietin Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Human Erythropoietin Market Share by Regions (2016-2021)
Table 10. Global Human Erythropoietin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Human Erythropoietin Market Share by Regions (2022-2027)
Table 12. Human Erythropoietin Market Trends
Table 13. Human Erythropoietin Market Drivers
Table 14. Human Erythropoietin Market Challenges
Table 15. Human Erythropoietin Market Restraints
Table 16. Global Human Erythropoietin Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Human Erythropoietin Market Share by Players (2016-2021)
Table 18. Global Top Human Erythropoietin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Erythropoietin as of 2020)
Table 19. Ranking of Global Top Human Erythropoietin Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Human Erythropoietin Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Human Erythropoietin Product Solution and Service
Table 23. Date of Enter into Human Erythropoietin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Human Erythropoietin Revenue Market Share by Type (2016-2021)
Table 27. Global Human Erythropoietin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Human Erythropoietin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Human Erythropoietin Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Human Erythropoietin Revenue Market Share by Application (2016-2021)
Table 31. Global Human Erythropoietin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Human Erythropoietin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Human Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Human Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Human Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Human Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Human Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Human Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Human Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Human Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Human Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Human Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Human Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Human Erythropoietin Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Human Erythropoietin Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Human Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Human Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Human Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Human Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Human Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Human Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Human Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Human Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Human Erythropoietin Product
Table 66. Amgen Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Human Erythropoietin Product
Table 71. Johnson & Johnson Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Human Erythropoietin Product
Table 76. Roche Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Galenica Company Details
Table 79. Galenica Business Overview
Table 80. Galenica Human Erythropoietin Product
Table 81. Galenica Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 82. Galenica Recent Development
Table 83. Emcure Company Details
Table 84. Emcure Business Overview
Table 85. Emcure Human Erythropoietin Product
Table 86. Emcure Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 87. Emcure Recent Development
Table 88. Kyowa Hakko Kirin Company Details
Table 89. Kyowa Hakko Kirin Business Overview
Table 90. Kyowa Hakko Kirin Human Erythropoietin Product
Table 91. Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 92. Kyowa Hakko Kirin Recent Development
Table 93. 3SBio Company Details
Table 94. 3SBio Business Overview
Table 95. 3SBio Human Erythropoietin Product
Table 96. 3SBio Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 97. 3SBio Recent Development
Table 98. Biocon Company Details
Table 99. Biocon Business Overview
Table 100. Biocon Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 101. Biocon Recent Development
Table 102. LG Life Sciences Company Details
Table 103. LG Life Sciences Business Overview
Table 104. LG Life Sciences Human Erythropoietin Product
Table 105. LG Life Sciences Revenue in Human Erythropoietin Business (2016-2021) & (US$ Million)
Table 106. LG Life Sciences Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Erythropoietin Market Share by Type: 2020 VS 2027
Figure 2. Epoetin-alfa Features
Figure 3. Epoetin-beta Features
Figure 4. Darbepoetin-alfa Features
Figure 5. Others Features
Figure 6. Global Human Erythropoietin Market Share by Application: 2020 VS 2027
Figure 7. Anemia Case Studies
Figure 8. Kidney Disorders Case Studies
Figure 9. Others Case Studies
Figure 10. Human Erythropoietin Report Years Considered
Figure 11. Global Human Erythropoietin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Human Erythropoietin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Erythropoietin Market Share by Regions: 2020 VS 2027
Figure 14. Global Human Erythropoietin Market Share by Regions (2022-2027)
Figure 15. Global Human Erythropoietin Market Share by Players in 2020
Figure 16. Global Top Human Erythropoietin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Erythropoietin as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Human Erythropoietin Revenue in 2020
Figure 18. Global Human Erythropoietin Revenue Market Share by Type (2016-2021)
Figure 19. Global Human Erythropoietin Revenue Market Share by Type (2022-2027)
Figure 20. North America Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Human Erythropoietin Market Share by Type (2016-2027)
Figure 22. North America Human Erythropoietin Market Share by Application (2016-2027)
Figure 23. North America Human Erythropoietin Market Share by Country (2016-2027)
Figure 24. United States Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Erythropoietin Market Share by Type (2016-2027)
Figure 28. Europe Human Erythropoietin Market Share by Application (2016-2027)
Figure 29. Europe Human Erythropoietin Market Share by Country (2016-2027)
Figure 30. Germany Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Erythropoietin Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Human Erythropoietin Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Human Erythropoietin Market Share by Region (2016-2027)
Figure 40. China Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Erythropoietin Market Share by Type (2016-2027)
Figure 48. Latin America Human Erythropoietin Market Share by Application (2016-2027)
Figure 49. Latin America Human Erythropoietin Market Share by Country (2016-2027)
Figure 50. Mexico Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Erythropoietin Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Human Erythropoietin Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Human Erythropoietin Market Share by Country (2016-2027)
Figure 56. Turkey Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Human Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Amgen Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 62. Galenica Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 63. Emcure Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 64. Kyowa Hakko Kirin Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 65. 3SBio Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 66. Biocon Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 67. LG Life Sciences Revenue Growth Rate in Human Erythropoietin Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---